Skip to main content
Clinical Trials/NCT06337968
NCT06337968
Not yet recruiting
Not Applicable

Circum-Psoas Block for Arthroscopic Hip Surgery: a Randomized Trial

The Second Hospital of Shandong University0 sites74 target enrollmentDecember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Pain
Sponsor
The Second Hospital of Shandong University
Enrollment
74
Primary Endpoint
pain severity at 6 hours postoperatively
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

Arthroscopic hip surgery is being increasingly performed to treat both intraarticular and extraarticular hip diseases. Despite the minimally invasive approach, patients undergoing arthroscopic hip surgery still suffer severe pain due to the complex nature of hip innervation. Postoperative pain reduces patient satisfaction and delay patient recovery and discharge. The efficacy of regional anesthesia techniques in postoperative pain management have been proved in various surgeries. However, it remains controversial whether or not peripheral nerve blocks can significantly improve postoperative analgesia after hip arthroscopy.

Several studies have shown that the fascia iliac block cannot improve postoperative analgesia for hip arthroscopy because it blocks only some branches of the lumbar plexus but not the sacral plexus. Circum-Psoas Block (CPB) which has been defined in recent years is able to block the lumbar plexus nerves as well as sacral plexus such as the sciatic, superior gluteal, and inferior gluteal nerves. Therefore, the investigators predict that it can provide effective postoperative analgesia for hip arthroscopy. In this study, the researchers aim to investigate the effectiveness of CPB in hip arthroscopy.

Registry
clinicaltrials.gov
Start Date
December 1, 2024
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Primary unilateral ambulatory hip arthroscopy
  • Age 18 to 70 years
  • ASA physical status I to III
  • Ability to follow the protocol.

Exclusion Criteria

  • Age \<18 or \>70 years of age
  • BMI above 40
  • Contraindications to peripheral nerve blockade
  • Pregnancy
  • Chronic pain condition requiring opioid intake at home
  • Allergy to opioids or local anesthetics
  • Patient refusal

Outcomes

Primary Outcomes

pain severity at 6 hours postoperatively

Time Frame: 6 hours postoperatively

Postoperative pain assessed with NRS pain score (NRS 0: no pain 10: pain as bad as can be) at 1, 6, 12, 24 hours postoperatively. However, to be more precise in our assessment, the effectiveness of each intervention was defined as a reduction in the pain at 6 hours postoperatively.

Secondary Outcomes

  • Postoperative opioid consumption(up to the first 24 hours postoperatively)
  • Postoperative nausea and vomiting(up to the first 24 hours postoperatively)
  • neurologic evaluation(1, 6, 24 hours postoperatively)
  • Patient satisfaction(at the end of 24 hours postoperatively)

Similar Trials